Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection
Publication Type:
Journal Article
Authors:
Feld, Jordan J.;
Ira M. Jacobson;
Christophe Hézode;
Asselah, Tarik;
Ruane, Peter J.;
Gruener, Norbert;
Abergel, Armand;
Mangia, Alessandra;
Lai, Ching-Lung;
Chan, Henry L. Y.;
Mazzotta, Francesco;
Moreno, Christophe;
Yoshida, Eric;
Shafran, Stephen D.;
Towner, William J.;
Tran, Tram T.;
McNally, John;
Osinusi, Anu;
E. S. Svarovskaia;
Zhu, Yanni;
Brainard, Diana M.;
McHutchison, John G.;
Agarwal, Kosh;
Stefan Zeuzem;
ASTRAL-1 InvestigatorsSource:
N Engl J Med, Volume 373, Issue 27, p.2599-2607 (2015)
Keywords:
Adult,
Aged,
Aged, 80 and over,
Antiviral Agents,
Carbamates,
Double-Blind Method,
Drug Combinations,
Drug Resistance, Viral,
Female,
Genotype,
Hepacivirus,
Hepatitis C, Chronic,
Heterocyclic Compounds, 4 or More Rings,
Humans,
Liver Cirrhosis,
Male,
Middle Aged,
Recurrence,
sofosbuvir,
Treatment Outcome,
Viral Nonstructural Proteins
